News Highlights:
- Harvard-led delegation of 85 global health experts commended the NASENI-TROMENT Biotechnologies factory, describing it as a major boost to malaria eradication and infectious disease control efforts in Africa.
- The facility, Africa’s first fully localized RDT kit factory, is designed to produce 600 million diagnostic kits annually, reducing dependence on imports and strengthening Nigeria’s healthcare sovereignty.
Nigeria’s drive toward healthcare self-reliance received a major endorsement from the global scientific community as about 85 medical professionals, scientists, and policymakers from across the world lauded the establishment of the NASENI-TROMENT Biotechnologies factory, describing it as a significant step toward defeating malaria and other infectious diseases in Africa.
The experts, who are participating in the “Science of Defeating Malaria” leadership development programme organised by Harvard University, USA, gave the commendation during a tour of the multi-million-dollar diagnostic manufacturing facility on Sunday, June 7, 2027.
Impressed by the factory’s capacity for the local production of Polymerase Chain Reaction (PCR) kits and Rapid Diagnostic Tests (RDTs), the delegation noted that the facility represents a bold investment in indigenous healthcare innovation and a critical milestone in building Africa’s disease surveillance and diagnostic capabilities.
They particularly praised the emergence of a wholly Nigerian-owned diagnostic brand capable of supporting efforts to combat malaria and other infectious diseases across the continent.
Speaking during the visit, Chief Executive Officer and Co-Founder of NASENI-TROMENT Biotechnologies, Mr. Selim Hani, explained that the factory was established through a strategic partnership between the National Agency for Science and Engineering Infrastructure (NASENI) and Troment Nigeria Limited.
According to him, the collaboration is designed to strengthen Nigeria’s healthcare sovereignty by promoting the local production of high-quality diagnostic technologies, reducing dependence on imports, and enhancing the country’s capacity to respond effectively to public health challenges.
“This facility, built from ground zero in the last 18 months, focuses on the manufacturing of RDTs and in vitro diagnostic (IVD) products, enabling early detection of major infectious and public health diseases. Diagnostic test kits under the N-CheckUP brand will be produced to test Malaria, Hepatitis B & C, HIV ½, Pregnancy, COVID-19 Antigen, Typhoid, Syphilis, Blood Glucose, among others.
“It is designed to produce 600 million diagnostic kits per year. It will reduce Nigeria’s (and West Africa’s) reliance on imported medical diagnostics while improving accessibility and affordability across the country and the African region,” he added.
Technical Partner, NASENI-Troment Biotechnologies, Dr. Engin Narinc, said, “This facility is Africa’s first fully localized Rapid Diagnostic Test (RDT) kit factory. From concept to full-scale launch, our end-to-end production process is designed to deliver world-class diagnostic solutions built entirely in Africa, for Africa.”
Team lead, Science of Defeating Malaria Initiative, Professor Dyann F. Wirth, Harvard University, USA, and one of the world’s leading malariologists, led the team on a tour of the various sections of the factory. She said, “This is an amazing facility that would add value to the eradication of malaria and other public health diseases in Nigeria and the continent.”
The visiting Science of Defeating Malaria leadership development course and initiative is currently holding its programme from June 7-13, 2026, in Abuja, Nigeria. It trains global health professionals, scientists, and policymakers to eliminate and eradicate malaria.
